Gerresheimer prepared for Covid-19 vaccination campaigns

Published 20th July, 2020 by Greg Morris

Gerresheimer sees medium to long term growth opportunities in its pharma business, CEO Dietmar Siemssen said.

Glass manufacturer Gerresheimer sees medium and long-term growth opportunities in the pharmaceutical business as a result of the corona pandemic.

"We are prepared for the high demand for injection vials for the upcoming vaccination campaigns and are further expanding our capacities," said CEO Dietmar Siemssen when presenting the quarterly results.

Gerresheimer generated sales of €363 million in the second quarter (as of May 31, 2020), an increase of 4.6% compared to the same quarter of the previous year.

Temporarily reduced demand for high-quality perfume flacons has been more than offset by increased demand for drug packaging and drug delivery devices, it added.

Greg Morris

Glass International Editor

Greg Morris has been editor of Glass International and organiser of the Glassman conferences since 2012, specialising in glass packaging. Prior to this he spent five years working in newspaper journalism.